Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era

References

• Ammassari A, Cingolani A, Pezzotti P, De Luca A, Murri R, Giancola ML, Larocca LM, Antinori A (2000). AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 55: 1194–1200.
   PubMedGoogle Scholar
• Antinori A, Ammassari A, Cinque P, Toma L, Govoni A, Soldani F, Giancola ML, Grisetti S, Pierotti C, Fausti C, Finazzi MG, Bini T, Del Grosso B, Cristiano L, Corsi P, Fa-sub o G, Mena M, Guaraldi G, Arcidiacono MI, Monno L, Gigli B, Fibbia GC, Gentile M, Mastroianni A, Speranza F, d'Arminio Monforte A, Rezza G, Ippolito G (2001a). Shift of prevalence and selected characteristics in HIV-1 related neurologic disorders in HAART era: data from Italian Register Investigative Neuro AIDS (IRINA). 8th Conference on Retroviruses and Opportunistic Infec-tions. Chicago, IL, February 4–8, 2001 (Abstract 8).
   Google Scholar
• Antinori A, Giancola ML, Soldani F, Grisetti S, Galgani S, Tozzi V, Gigli B, Gentile M, Busi E, Martini F, Calcaterra S, Girardi E, Ippolito G (2001b). Long term survival in HIV-1 infected patients with neurological disorders treated with HAART: analysis of clinical, immuno-logical and virological predictors. 8th Conference on Retroviruses and Opportunistic Infections. Chicago, IL, February 4–8, 2001 (Abstract 599).
   Google Scholar
• Autran B, Carcelain G, Li TS, Blanc C, Mathez D, Tubiana R, Katlama C, Debre P, Leibowitch J (1997). Positive ef-fects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Sci-ence 277: 112–116.
   PubMed Web of Science ®Google Scholar
• Beck EJ, Mandalia S, Williams I, Power A, Newson R, Molesworth A, Barlow D, Easterbrook P, Fisher M,
   Google Scholar
• Innes J, Kinghorn G, Mandel B, Pozniak A, Tang A, Tom-linson D for the National Prospective Monitoring Sys-tem Steering Group (1999). Decreasedmorbidity and use of hospital services in English HIV-infected individuals with increased uptake of antiretroviral therapy 1996–1997. AIDS 13: 2157–2164.
   Google Scholar
• Berger JR, Kaszovitz B, Donovan Post MJ, Dickinson G (1987). Progressive multifocal leukoencephalopathy as-sociated with human immunodeficiency virus infection. Ann Intern Med 107: 78–87.
   PubMed Web of Science ®Google Scholar
• Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998). Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44: 341–349.
   Google Scholar
• Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB (1997). Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination ther-apy. AIDS 11: 1731–1738.
   PubMed Web of Science ®Google Scholar
• Cinque P, Casari S, Bertelli D (1998). Progressive mul-tifocal leukoencephalopathy, HIV, and Highly Ac-tive Antiretroviral Therapy. N Engl I Med 339: 848–849.
   Google Scholar
• Clifford DB, Yiannoutsos C, Glicksman M, Simpson DM, Singer EJ, Piliero PJ, Marra CM, Francis GS, McArthur JC, Tyler KL, Tselis AC, Hyslop NE (1999). HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 52: 623–625.
   PubMed Web of Science ®Google Scholar
• Collazos J, Mayo J, Martinez E, Blanco MS (1999). Contrast-enhancing progressive multifocal leukoencephalopathy as an immune reconstitution event in AIDS patients. AIDS 13: 1426–1428.
   PubMed Web of Science ®Google Scholar
• d'Arminio Monforte A, Duca PG, Vago L, Grassi MP, Moroni M (2000). Decreasing incidence of CNS AIDS-defining events associated with antiretroviral therapy. Neurology 54: 1856–1859.
   Google Scholar
• De Luca A, Giancola ML, Ammassari A, Grisetti S, Paglia MG, Gentile M, Cingolani A, Murri R, Liuzzi G, d'Arminio Monforte A, Antinori A (2000). The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifo-cal leukoencephalopathy. I Infect Dis 182: 1077–1083.
   PubMed Web of Science ®Google Scholar
• De Luca A, Giancola ML, Cingolani A, Ammassari A, Gillini L, Murri R, Antinori A (1999). Clinical and virologi-cal monitoring during treatment with intrathecal cytara-bine in patients with AIDS-associated progressive mul-tifocal leukoencephalopathy. Clin Infect Dis 28: 624–628.
   PubMed Web of Science ®Google Scholar
• Dworkin MS, Wan PC, Hanson DL, Jones JL,, and the Adult and Adolescent Spectrum of HIV Disease Project (1999). Progressive multifoc al leukoencephalopathy: improved survival of human immunodeficiency virus-infected pa-tients in the protease inhibitor era. /Infect Dis 180: 621–625.
   PubMed Web of Science ®Google Scholar
• Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson H, Grant I, McCutchan JA, and the HIV Neurobehavioral Research Center Group (1997). Cerebrospinal fluid human immuno-deficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 42: 679–688.
   PubMed Web of Science ®Google Scholar
• Fong IW, Toma E, and the Canadian PML Study Group (1995). The natural history of progressive multifocal leukoencephalopathy in patients with AIDS. Clin Infect Dis 20: 1305–1310.
   PubMed Web of Science ®Google Scholar
• Gasnault J, Taoufik Y, Goujard C, Kousignian P, Abbed K, Boue F, Dussaix E, Delfraissy JF (1999). Pro-longed survival without neurological improvement in patients with AIDS-related progressive multifocal leukoencephalopathy on potent combined antiretrovi-ral therapy. J NeuroVirol 5: 421–429.
   PubMed Web of Science ®Google Scholar
• Giancola ML, Tartaglione T, Ammassari A, Settecasi C, Cingolani A, Larussa D, Murri R, De Luca A (2000). Neu-rological and virologic predictors of survival in AIDS-associated progressive multifocal leukoencephalopathy (PML): the role of HAART. XIII International Con-ference on AIDS. Durban, July 9–14, 2000. (Abstract TuOrB358.)
   Google Scholar
• Giudici B, Vaz B, Bossolasco S, Casari S, Brambilla AM, Luke W, Lazzarin A, Weber T, Cinque P (2000). Highly Active Antiretroviral Therapy and progressive multifo-cal leukoencephalopathy: effects on cerebrospinal fluid markers of JC virus replication and immune response. Clin Infect Dis 30: 95–99.
   PubMed Web of Science ®Google Scholar
• Koralnik IJ, Boden D, Mai VX, Lord CI, Letvin NL (1999). JC virus DNA load in patients with and without pro-gressive multifocal leukoencephalopathy. Neurology 52: 253–260.
   Google Scholar
• Ledergerber B, Egger M, Erard V, Weber R, Hirschel B, Furrer H, Battegay M, Vernazza P, Bernasconi E, Opravil M, Kaufmann D, Sudre P, Francioli P, Telenti A, and the Swiss Cohort Study (1999). AIDS-related opportunistic illnesses occurring after initiation of potent antiretro-viral therapy: the Swiss HIV Cohort Study. JAMA 282: 2220–2226.
   PubMed Web of Science ®Google Scholar
• Mayo J, Collazos J, Martinez E (1998). Progressive mul-tifocal leukoencephalopathy following initiation of highly active antiretroviral therapy. AIDS 12: 1720–1722.
   PubMed Web of Science ®Google Scholar
• Pallella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD, and the HIV Outpatient Study Investigators (1998). Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 338: 853–860.
   Google Scholar
• Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Seines OA, Miller EN, Becker JT, Cohen B, McArthur JC, and the Multicenter AIDS Cohort Study (2001). HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990–1998. Neurology 56: 257–260.
   Google Scholar
• Tantisiriwat W, Tebas P, Clifford DB, Powderly J, Fichtenbaum CJ (1999). Progressive multifocal leukoen-cephalopathy in patients with AIDS receiving highly active antiretroviral therapy. Clin Infect Dis 28: 1152–1154.
   PubMedGoogle Scholar
• Taoufik Y, Delfraissy JF, Gasnault J (2000). Highly active antiretroviral therapy does not improve survival of pa-tients with high JC virus load in the cerebrospinal fluid at progressive multifocal leukoencephalopathy diagno-sis. AIDS 14: 758–759.
   PubMed Web of Science ®Google Scholar
• Taoufik Y, Gasnault J, Karaterki A, Ferey MP, MarchadierE, Goujard C, Lannuzel A, Delfraissy JF, Dussaix E (1998). Prognostic value of JC virus load in cerebr ospinal fluid of patients with progressive multifocal leukoencephalopa-thy. J Infect Dis 178: 1816–1820.
   PubMed Web of Science ®Google Scholar
• Tassie JM, Gasnault J, Bentata M, Deloumeaux J, Boué F, Billaud E, Costagliola D, and the Clinical Epidemiol-ogy Group from the French Hospital Database on HIV (1999). Survival improvement of AIDS-related progres-sive multifocal leukoencephalopathy in the era of pro-tease inhibitors. AIDS 13: 1881–1887.
   PubMed Web of Science ®Google Scholar
• Yiannoutsos CT, Major EO, Curfman B, Jensen PN, Gravell M, Hou J, Clifford D, Hall CD (1999). Relation of JC virus DNA in the cerebrospinal fluid to survival in acquired immunodeficiency syndrome patients with biopsy-proven progressive multifocal leukoencephalopathy. Ann Neurol 45: 816–820.
   PubMed Web of Science ®Google Scholar